ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development

He, HQ; Hao, J; Dong, X; Wang, Y; Xue, H; Qu, SF; Choi, SYC; Ci, XP; Wang, Y; Wu, R; Shi, MC; Zhao, XK; Collins, C; Lin, D; Wang, YZ

Wang, YZ (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada.; Wang, YZ (corresponding author), BC Canc Res Ctr, Dept Expt Therapeut, Vancouver, BC, Canada.

PROSTATE CANCER AND PROSTATIC DISEASES, ; ():